Aptorum Group Limited (APM) Financial Ratios
8 years of historical data (2017–2024) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.39
↓-80% vs avg
5yr avg: 1.91
30Y Low0.7·High31.0
ROE
↓
-31.4%
↓+20% vs avg
5yr avg: -39.3%
30Y Low-90%·High27%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
APM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Aptorum Group Limited currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $5M | $15M | $11M | $20M | $53M | $78M | $460M | $424M | — |
| Enterprise Value | $7M | $18M | $13M | $25M | $45M | $78M | $461M | $422M | — |
| P/E Ratio → | -1.07 | — | — | — | — | 12.35 | — | — | — |
| P/S Ratio | — | — | 25.68 | 15.15 | 34.08 | 85.44 | 859.19 | 1104.90 | — |
| P/B Ratio | 0.39 | 1.30 | 0.72 | 2.51 | 3.00 | 2.04 | 30.96 | 12.94 | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
APM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 29.11 | 18.98 | 28.94 | 85.25 | 861.59 | 1100.44 | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | 15.05 | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
APM Profitability
Margins and return-on-capital ratios measuring operating efficiency
Operating margins have compressed from -1351.0% to -2457.5% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -31.4% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 2.4% | 6.2% | 5.3% | -11.4% | -48.4% | 17.1% | — |
| Operating Margin | — | — | -2457.5% | -1351.0% | -1245.6% | -2182.6% | -3400.4% | -2693.4% | — |
| Net Profit Margin | — | — | -654.9% | -756.2% | -1624.4% | 775.3% | -3491.8% | -3868.0% | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -31.4% | -31.4% | -24.3% | -77.3% | -90.0% | 26.7% | -78.5% | -47.1% | -8.4% |
| ROA | -23.2% | -23.2% | -13.6% | -45.8% | -75.7% | 20.7% | -54.1% | -38.7% | -8.1% |
| ROIC | -18.3% | -18.3% | -53.6% | -117.3% | -60.6% | -55.1% | -57.9% | -34.1% | -29.5% |
| ROCE | -25.0% | -25.0% | -78.8% | -135.2% | -66.4% | -64.5% | -67.2% | -32.7% | -18.8% |
APM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $2M ($3M total debt minus $874238 cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.28 | 0.28 | 0.23 | 0.88 | 0.01 | 0.09 | 0.44 | 0.31 | 0.02 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.21 | 0.10 | 0.63 | -0.45 | -0.00 | 0.09 | -0.05 | -0.52 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -25.84 | -25.84 | -87.51 | — | -205.20 | -81.66 | -4.92 | -2.32 | — |
APM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.22x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.57x to 0.22x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | 0.22 | 1.18 | 0.57 | 2.90 | 8.70 | 3.00 | 2.36 | 15.24 |
| Quick Ratio | 0.22 | 0.22 | 1.18 | 0.56 | 2.89 | 8.69 | 2.99 | 2.35 | 14.09 |
| Cash Ratio | 0.20 | 0.20 | 0.96 | 0.16 | 1.91 | 8.24 | 2.34 | 1.07 | 13.69 |
| Asset Turnover | — | — | 0.02 | 0.06 | 0.07 | 0.02 | 0.02 | 0.01 | — |
| Inventory Turnover | 43.86 | — | — | 43.86 | 40.81 | 25.94 | 23.24 | 10.38 | 0.04 |
| Days Sales Outstanding | — | — | 60.03 | 332.53 | 842.90 | 136.57 | 332.55 | 943.17 | — |
APM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Aptorum Group Limited does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | 1.0% | — | — | — |
| Payout Ratio | — | — | — | — | — | 10.7% | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 8.1% | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M |
Peer Comparison
Compare APM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 APMYou | $5M | -1.1 | — | — | — | — | -31.4% | -18.3% | — |
 CASI | $2M | -0.1 | — | — | 39.1% | -138.8% | -301.8% | -153.0% | — |
 ZLAB | $2B | -11.4 | — | — | 58.5% | -48.6% | -22.6% | -41.7% | — |
 NVAX | $2B | 3.6 | 2.6 | — | 93.7% | 50.1% | — | — | 0.4 |
 AEYE | $79M | -25.2 | 224.1 | 16.8 | 78.3% | -7.9% | -43.2% | -20.1% | 34.1 |
 AYTU | $19M | -1.1 | — | — | 69.0% | -11.8% | -58.1% | -33.5% | — |
 CLOV | $3B | -29.4 | — | — | 18.5% | -4.4% | -26.3% | -34.0% | — |
 HCM | $2B | 4.0 | — | — | 38.7% | -10.0% | 45.3% | -4.1% | — |
 CNTB | $126M | -2.0 | — | — | 100.0% | -90740.6% | -82.7% | -472.5% | — |
 REYN | $5B | 16.7 | 10.6 | 15.9 | 24.6% | 13.2% | 13.7% | 9.6% | 2.8 |
 CRL | $9B | -63.6 | 12.9 | 17.2 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
APM — Frequently Asked Questions
Quick answers to the most common questions about buying APM stock.
What is Aptorum Group Limited's P/E ratio?
Aptorum Group Limited's current P/E ratio is -1.1x. The historical average is 12.3x.
What is Aptorum Group Limited's ROE?
Aptorum Group Limited's return on equity (ROE) is -31.4%. The historical average is -41.3%.
Is APM stock overvalued?
Based on historical data, Aptorum Group Limited is trading at a P/E of -1.1x. Compare with industry peers and growth rates for a complete picture.